Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2795892A - Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes - Google Patents
[go: Go Back, main page]

AU2795892A - Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes - Google Patents

Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes

Info

Publication number
AU2795892A
AU2795892A AU27958/92A AU2795892A AU2795892A AU 2795892 A AU2795892 A AU 2795892A AU 27958/92 A AU27958/92 A AU 27958/92A AU 2795892 A AU2795892 A AU 2795892A AU 2795892 A AU2795892 A AU 2795892A
Authority
AU
Australia
Prior art keywords
immunoadhesins
plasmodium falciparum
selectively killing
infected erythrocytes
erythrocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27958/92A
Inventor
Timothy A. Springer
Donald E. Staunton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Center for Blood Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Center for Blood Research Inc filed Critical Center for Blood Research Inc
Publication of AU2795892A publication Critical patent/AU2795892A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU27958/92A 1991-10-03 1992-10-05 Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes Abandoned AU2795892A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US899061 1986-08-22
US76962591A 1991-10-03 1991-10-03
US769625 1991-10-03
US86270892A 1992-04-03 1992-04-03
US862708 1992-04-03
US89906192A 1992-06-12 1992-06-12

Publications (1)

Publication Number Publication Date
AU2795892A true AU2795892A (en) 1993-05-03

Family

ID=27419657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27958/92A Abandoned AU2795892A (en) 1991-10-03 1992-10-05 Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes

Country Status (2)

Country Link
AU (1) AU2795892A (en)
WO (1) WO1993006848A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367059A (en) * 1992-05-14 1994-11-22 W. R. Grace & Co.-Conn. Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
GB9915311D0 (en) * 1999-06-30 1999-09-01 Isis Innovation Modulation of dendritic cell maturation
GB9927502D0 (en) * 1999-11-19 2000-01-19 Isis Innovation CD36 Polymorphisms
US8921534B2 (en) 2001-12-12 2014-12-30 Sanofi Pasteur Limited Enhancement of the immune response using CD36-binding domain
PL2298347T3 (en) * 2003-05-06 2016-03-31 Bioverativ Therapeutics Inc Coagulation factor chimeric proteins for the treatment of a hemostatic disorder
EP3077048B1 (en) * 2013-12-07 2019-07-17 Case Western Reserve University Compositions and methods of treating thrombosis

Also Published As

Publication number Publication date
WO1993006848A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AU1081292A (en) New beta-amino- alpha-hydroxycarboxylic acids and their use
IL102704A0 (en) Dna coding for human serum albumin and its use
AU3429789A (en) Antipilferage tags and their use
IL100741A0 (en) N-phenylsulfonyl-n'-pyrimidinyl-,-n'-triazinyl-and-n'-triazolylureas and-thioureas,their preparation and their use as herbicides
IL93055A0 (en) Polyimidesiloxanes,their preparation and use
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
IL90690A0 (en) Tissue equivalents and their preparation
ZA926189B (en) Beta-Phenylisoserine derivatives and their preparation and use.
AU2966392A (en) Transparent part and use thereof
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
AU2795892A (en) Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes
AU2797892A (en) (plasmodium falciparum)-infected erythrocytes binding to icam-1 and cd36
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
ZA922952B (en) 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy
AU5836390A (en) Human lymphoma-associated virus
AU3003592A (en) Transparent part and use thereof
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
EP0701557A4 (en) Lavendamycin analogs, their use and preparation
EP0442086A3 (en) Graftcopolymers, their preparation and their use
AU5023990A (en) Improvements in oyster and shrimp winches
ZA922832B (en) Sulfonamides and their medical use
ZA918998B (en) 3h-purines,their preparation and use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
GR900300184T1 (en) Preparation and its use
IL97458A0 (en) Antiviral protein and its preparation